- Home
- OPK vs BTX Comparison
OPK vs BTX Comparison
Compare OPK & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPK | BTX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 780.8M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | OPK | BTX |
|---|---|---|
| Price | $1.13 | $6.64 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $2.03 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 653.6K |
| Earning Date | 04-29-2026 | 11-01-2025 |
| Dividend Yield | N/A | ★ 12.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.76 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.10 | $5.10 |
| 52 Week High | $1.81 | $7.50 |
Technical Indicators
Market Signals| Indicator | OPK | BTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.99 | 52.88 |
| Support Level | $1.13 | $6.55 |
| Resistance Level | $1.27 | $6.92 |
| Average True Range (ATR) | 0.04 | 0.17 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 45.83 | 72.03 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About BTX BlackRock Technology and Private Equity Term Trust
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.